This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

November 4–6, 2024Stockholm, Sweden

Linus Lin
Manging Director at Chorus, Eli Lilly and Company


Dr. Linus S. Lin is the Global Head of Lilly Chorus, an operationally independent early development unit that specializes from IND enabling to lean clinical Proof of Concept (POC). Chorus is housed within the Lilly External Innovation organization with the mission to enable biotech ecosystem and accelerate breakthrough science to medicine.

Previously at Lilly, he held the positions of Site Head & General Manager, Lilly China Research and Development Center (LCRDC), a diabetes focused R&D center based in Shanghai, and Head, Lilly China Innovation Partnerships (LCIP), an externally focused organization to engage biotech and academic collaborators in China.Prior to Lilly, Dr. Lin led the Chemistry Service Unit at WuXi AppTec, the top discovery CRO brand in the industry. He started his industry career as a medicinal chemist at Merck Research Laboratories. Over a 15-year span at Merck, he led multiple drug discovery teams delivering 9 preclinical candidates, including 4 completing PhI studies and one completing PhIII studies.

Dr. Lin received his BS in Chemistry from Peking University, obtained his PhD in Organic Chemistry at the University of Wisconsin-Madison, and completed his NIH postdoctoral Fellowship with Nobel laureate Prof. E. J. Corey at Harvard University.

Agenda Sessions

  • How biotechs are benefitting from the close collaboration between CROs, VCs, and the fundraising/partnering community